Human tumour xenografts growing in immunodeficient mice: a useful model for assessing chemotherapeutic agents in bronchial carcinoma.
AUTOR(ES)
Fergusson, R J
RESUMO
Xenografts from eight human bronchial carcinomas have been established in CBA/Lac mice rendered immunodeficient by neonatal thymectomy followed three weeks later by whole body irradiation (7.35 Gy (735 rads)) after a priming dose of cytosine arabinoside. Growth rates of individual tumour lines remain constant and the histological and chromosomal characteristics of the original tumour are maintained through multiple serial passages over many months. With specific growth delay as the principal end point this system may be used to assess the response of histologically different lung tumours to chemotherapeutic agents.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1020631Documentos Relacionados
- Value of radiotherapy for tumour on the bronchial stump after resection for bronchial carcinoma.
- Human Embryonic Gastric Xenografts in Nude Mice: a New Model of Helicobacter pylori Infection
- Implications of histologically reported residual tumour on the bronchial margin after resection for bronchial carcinoma.
- Role of lung scanning in assessing the resectability of bronchial carcinoma.
- Role of lung scanning in assessing the resectability of bronchial carcinoma.
